![](https://investorshub.advfn.com/uicon/756666.png?cb=1598094430)
Wednesday, September 30, 2020 9:02:16 AM
- Enough immediate production capacity to meet US stockpile needs will raise revenue estimates... and that's just US stockpile. There's still the rest of the world that will be banging on our door for supply.
- I am 99.99% confident we will obtain EUA approval and FDA approval on both the IV and the inhaler.
- I am 99.99% confident Aviptadil will have other significant applications.
- I am 99.99% confident we will hit mainstream media within October.
- The IV for covid, the inhaler for treating mild to severe covid, the inhaler for preventative treatment of covid, Aviptadil for other lung issues, Aviptadil for other biological issues... this is a very serious long-term play.
- I am 99% confident we get a Nasdaq uplisting or buyout of $50B+ (likely both)
You and I bought this thing for under 65c... who knew an OTC penny would have real potential like this.
Disclaimer: I am not a professional advisor. Seek professional advice before investing or trading. I take risky positions and do not advise anyone to follow my opinions or actions.
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM